Form 4: Beneficient Executive Jeff Welday Sells Shares to Cover Tax Obligations
SEC Form 4
Beneficient's Global Head of Organizations and Distribution, Jeff Welday, sold a portion of his Class A common stock to cover tax obligations related to vested restricted stock units.
Summary
- Jeff Welday, Global Head of Organizations and Distribution at Beneficient, sold a total of 6,503 shares of Class A common stock between November 26 and November 29, 2024.
- The sales were executed at prices ranging from $0.88 to $1.00 per share.
- These transactions were made to cover tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs).
- Following these transactions, Welday still beneficially owns 108,730 shares of Class A common stock.
- The reported holdings include shares issuable upon the settlement of various RSU and REU awards granted under the company's 2018 and 2023 Equity Incentive Plans.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation. There is no indication of positive or negative sentiment, it is a neutral event.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Executive stock sales are a common occurrence, particularly when tied to vesting schedules of equity compensation. This transaction is not unusual and is a normal part of executive compensation practices.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
- The vesting schedules and equity incentive plans described are typical for companies using equity as part of their compensation packages.
- The sale prices are within the range of recent trading activity for Beneficient stock, suggesting no unusual market behavior.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price, but are unlikely to have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 01/01/2020 | Date of grant for 140,490 REUs under the 2018 Equity Incentive Plan, vesting 20% on grant date and the remaining 80% in four equal annual installments on June 3rd of each subsequent calendar year. |
| 04/01/2022 | Date of grant for 7,200 REUs under the 2018 Equity Incentive Plan, vesting 40% on June 8, 2023, and the remaining 60% in three equal annual installments on April 1st of each subsequent calendar year. |
| 07/15/2023 | Date of grant for 28,320 RSUs under the 2023 Equity Incentive Plan, vesting 20% on September 1, 2023, and the remaining 80% in four equal annual installments on September 1st of each subsequent calendar year. |
| 07/15/2023 | Date of grant for 20,560 RSUs under the 2023 Equity Incentive Plan, fully vested on September 1, 2023. |
| 08/22/2024 | Date of grant for 98,919 RSUs under the 2023 Equity Incentive Plan, fully vested on the date of grant. |
| 08/22/2024 | Date of grant for 998 RSUs under the 2023 Equity Incentive Plan, fully vested on the date of grant. |
| 10/17/2024 | Date of grant for 58,249 RSUs under the 2023 Equity Incentive Plan, fully vested on the date of grant. |
| 11/26/2024 | First transaction date of stock sale, 3,081 shares sold at $1.00 per share. |
| 11/27/2024 | Second transaction date of stock sale, 2,247 shares sold at $0.92 per share. |
| 11/29/2024 | Third transaction date of stock sale, 1,175 shares sold at $0.88 per share. |
| 11/29/2024 | Date of filing of the Form 4. |
Keywords
Beneficient, Jeff Welday, stock sale, Form 4, insider trading, restricted stock units, RSU, REU, equity incentive plan, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.